Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,448 across all filing types
Latest filing 2019-05-07 Investor Presentation
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
8-K Filing
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2019, by Moderna, Inc. It primarily announces a live webcast event for the company's 2019 Science Day and a tour of its manufacturing facility. The document includes slide presentations as exhibits related to these events. The text explicitly states that the slide presentations are attached as exhibits and that the webcast information is available on the company's website. The document is short (4046 characters) and serves as a disclosure of an event and related presentations rather than a full report. The content fits the description of an Investor Presentation (IP) because it involves detailed presentations for investors focusing on company events and information. It is not an Annual Report, Earnings Release, or Regulatory Filing, and it is not merely an announcement of a report publication. Therefore, the best classification is Investor Presentation (IP).
2019-05-07 English
10-K/A Filing
Annual Report FY 2018
2019-04-25 English
10-K Filing
Annual Report FY 2018
2019-03-13 English
S-8 Filing
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Moderna, Inc. on March 13, 2019. Form S-8 is used to register securities to be offered under employee benefit plans, such as stock option and incentive plans. The document includes details about the number of shares registered, the stock option plan, and legal exhibits. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and capital changes. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement but a full registration statement filing.
2019-03-13 English
4 Filing
Director's Dealing
2019-03-11 English
4 Filing
Director's Dealing
2019-03-11 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.